Clinical Trials Browser

Phase 1 × terameprocol × Tumor-Agnostic × Clear all

NCT00259818 2008-01-24

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors

Phase 1 Completed

Neoplasms